Company intelligence / Profile preview

Shaman Pharmaceuticals

South San Francisco, California, USAshamanpharmaceuticals.com ↗

Ownership: Private
Development stage: Other

Overview

Shaman Pharmaceuticals was a pioneering biotech/pharma company founded in the late '80s that focused on discovering and developing drugs from tropical plants used in traditional medicine. The company advanced several candidates into clinical trials—including Crofelemer for AIDS-related diarrhea—but exited pharmaceutical R&D around early 1999 due to financial constraints and regulatory hurdles. It then pivoted toward herbal remedies under the name "Shaman Botanicals." Most pharmaceutical programs were discontinued by this point.

Therapeutic areas: GastroenterologyEndocrinologyInfectious Diseases
Modalities: Small molecules/natural products/botanicals
Industry: Biotech

Partnerships

Notable investors included Eli Lilly & Company; no major pharma partnerships reported before closure.

Beyond the preview

Go deeper on Shaman Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shaman Pharmaceuticals.